NCT00648791

Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg

Single-Dose Fasting In Vivo Bioequivalence Study of Finasteride Tablets (5 mg; Mylan) and Proscar Tablets (5 mg; Merck) in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 29 (actual)
• Sponsor: Mylan Pharmaceuticals Inc · Industry
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The objective of this study was to investigate the bioequivalence of Mylan's finasteride 5 mg tablets to Merck's Proscar® 5 mg tablets following a single, oral 5 mg (1 x 5 mg) dose administration under fasting conditions.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Finasteride Tablets 5 mg	5mg, single dose fasting
DRUG	Proscar Tablets 5 mg	5mg, single dose fasting

Timeline

• Start date: 2004-09-01
• Primary completion: 2004-10-01
• Completion: 2004-10-01
• First posted: 2008-04-01
• Last updated: 2024-04-24

Locations

1 site across 1 country: United States